Cargando…

Neurological Response to cART vs. cART plus Integrase Inhibitor and CCR5 Antagonist Initiated during Acute HIV

OBJECTIVE: To compare central nervous system (CNS) outcomes in participants treated during acute HIV infection with standard combination antiretroviral therapy (cART) vs. cART plus integrase inhibitor and CCR5 antagonist (cART+). DESIGN: 24-week randomized open-label prospective evaluation. METHOD:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valcour, Victor G., Spudich, Serena S., Sailasuta, Napapon, Phanuphak, Nittaya, Lerdlum, Sukalaya, Fletcher, James L. K., Kroon, Eugene D. M. B., Jagodzinski, Linda L., Allen, Isabel E., Adams, Collin L., Prueksakaew, Peeriya, Slike, Bonnie M., Hellmuth, Joanna M., Kim, Jerome H., Ananworanich, Jintanat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640512/ https://www.ncbi.nlm.nih.gov/pubmed/26555069 http://dx.doi.org/10.1371/journal.pone.0142600

Ejemplares similares

HIV DNA Reservoir Increases Risk for Cognitive Disorders in cART-Naïve Patients
por: Valcour, Victor G., et al.
Publicado: (2013)

Correction: HIV DNA Reservoir Increases Risk for Cognitive Disorders in cART-Naïve Patients
por: Valcour, Victor G., et al.
Publicado: (2014)

Change in Brain Magnetic Resonance Spectroscopy after Treatment during Acute HIV Infection
por: Sailasuta, Napapon, et al.
Publicado: (2012)

Effect of aprepitant on kynurenine to tryptophan ratio in cART treated and cART naïve adults living with HIV
por: Spitsin, Sergei, et al.
Publicado: (2021)

HIV-associated cognitive performance and psychomotor impairment in a Thai cohort on long-term cART
por: Do, Tanya C, et al.
Publicado: (2018)

Does transient cART started during primary HIV infection undermine the long-term immunologic and virologic response on cART resumption?
por: Krastinova, Evguenia, et al.
Publicado: (2015)

Association between obesity and combination antiretroviral therapy (cART) adherence among persons with early-stage HIV infection initiating cART
por: Musinguzi, Nicholas, et al.
Publicado: (2021)

Complete manuscript Title: Changes in RANKL during the first two years after cART initiation in HIV-infected cART naïve adults
por: Mathiesen, Inger Hee, et al.
Publicado: (2017)

Disseminated toxoplasmosis in an HIV positive patient in cART era
por: Cambrea, Simona Claudia, et al.
Publicado: (2014)

Bloodstream infections in patients living with HIV in the modern cART era
por: Taramasso, L., et al.
Publicado: (2019)

HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART
por: Jacobson, Caron A., et al.
Publicado: (2012)

Effect of once-daily FDC treatment era on initiation of cART
por: Mosen, David M, et al.
Publicado: (2010)

Monocytes as Regulators of Inflammation and HIV-Related Comorbidities during cART
por: Anzinger, Joshua J., et al.
Publicado: (2014)

Disruption of Timing: NeuroHIV Progression in the Post-cART Era
por: McLaurin, Kristen A., et al.
Publicado: (2019)

HIV and cART-Associated Dyslipidemia Among HIV-Infected Children
por: Tadesse, Birkneh Tilahun, et al.
Publicado: (2019)

Neuropsychiatric outcomes before and after switching to dolutegravir-based therapy in an acute HIV cohort
por: Chan, Phillip, et al.
Publicado: (2020)

Pre-cART Immune Parameters in People Living With HIV Might Help Predict CD8+ T-Cell Characteristics, Inflammation Levels, and Reservoir Composition After Effective cART
por: Salido, Jimena, et al.
Publicado: (2021)

Emergence of the G118R Pan-Integrase Resistance Mutation as a Result of Low Compliance to a Dolutegravir-Based cART
por: Mens, Helene, et al.
Publicado: (2022)

Switch to dolutegravir is well tolerated in Thais with HIV infection
por: Goh, Orlanda Q, et al.
Publicado: (2019)

Prediction of virological failure in HIV-infected individuals treated with cART in Suriname
por: Bleijenberg, MP, et al.
Publicado: (2010)

Virologic and Immunologic Response to cART by HIV-1 Subtype in the CASCADE Collaboration
por: Touloumi, Giota, et al.
Publicado: (2013)

Predictors of low ovarian reserve in cART-treated women living with HIV
por: Merlini, Esther, et al.
Publicado: (2021)

Determinants of suboptimal CD4(+) T cell recovery after antiretroviral therapy initiation in a prospective cohort of acute HIV‐1 infection
por: Handoko, Ryan, et al.
Publicado: (2020)

Multidisciplinary collaborative integrated management of increasingly prominent HIV complications in the post‐cART era
por: Lin, L, et al.
Publicado: (2020)

Decision making for invasive and non-invasive optional procedures within an acute HIV research cohort in Bangkok
por: Isaacson, Sinéad, et al.
Publicado: (2022)

Corrigendum to ‘Decision making for invasive and non-invasive optional procedures within an acute HIV research cohort in Bangkok,’ [Contemporary Clinical Trials Communication (2023)101054]
por: Isaacson, Sinéad, et al.
Publicado: (2023)

Discontinuation of cART postpartum in a high prevalence district of South Africa in 2014
por: Claessens, Lore, et al.
Publicado: (2014)

Is anemia still a problem in cART era: a single center study?
por: Genet, P, et al.
Publicado: (2014)

Impact of early cART on HIV blood and semen compartments at the time of primary infection
por: Chéret, Antoine, et al.
Publicado: (2017)

Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)
por: Bischoff, Jenny, et al.
Publicado: (2021)

MR spectroscopy in HIV associated neurocognitive disorder in the era of cART: a review
por: Chaganti, Joga, et al.
Publicado: (2021)

Improved induced innate immune response after cART initiation in people with HIV
por: Hove-Skovsgaard, Malene, et al.
Publicado: (2022)

Brief Report: Safety of Frequent Blood Sampling in Research Participants in an Acute HIV Infection Cohort in Thailand
por: Sacdalan, Carlo, et al.
Publicado: (2017)

Liver macrophage-associated inflammation correlates with SIV burden and is substantially reduced following cART
por: Fisher, Bridget S., et al.
Publicado: (2018)

The Cost-Effectiveness of Early Access to HIV Services and Starting cART in the UK 1996–2008
por: Beck, Eduard J., et al.
Publicado: (2011)

T-Cell Phenotypes, Apoptosis and Inflammation in HIV+ Patients on Virologically Effective cART with Early Atherosclerosis
por: Merlini, Esther, et al.
Publicado: (2012)

Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort
por: Capetti, Amedeo F., et al.
Publicado: (2016)

Resting-state subcortical functional connectivity in HIV-infected patients on long-term cART
por: Janssen, Marloes A. M., et al.
Publicado: (2016)

Maraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized Trial
por: van Lelyveld, Steven F. L., et al.
Publicado: (2015)

Self-reported adherence supports patient preference for the single tablet regimen (STR) in the current cART era
por: Sterrantino, G, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_unntb5mmafaal8kjssgbd6pjv9